Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034

Liquid Biopsy For Cancer Diagnostics Market 2025 – By Type (Product, Services), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers),By Sample (Blood, Urine, Saliva), By End User (Hospitals, Diagnostic Centers, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2035

Liquid Biopsy For Cancer Diagnostics Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 | Pages : 282 | Published : February 2025 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Liquid Biopsy For Cancer Diagnostics Market Definition

Liquid biopsy for cancer diagnostics refers to a minimally invasive technique that enables the detection and monitoring of cancer through the analysis of biomarkers present in body fluids such as blood, urine, or saliva. This diagnostic approach is increasingly transforming cancer care by offering a less invasive alternative to traditional tissue biopsies, which often require surgical procedures.

The liquid biopsy for cancer diagnostics market consists of sales, by entities (organizations, sole traders and partnerships) of liquid biopsy for cancer diagnostics products and services that are utilized by healthcare professionals for early cancer detection, tracking disease progression, monitoring treatment efficacy and detecting recurrence. These diagnostic tools are especially advantageous for cases where tissue biopsy is challenging or impossible, such as in advanced-stage cancers or when monitoring for residual disease.

Liquid Biopsy For Cancer Diagnostics Market Segmentation

The liquid biopsy for cancer diagnostics market is segmented by type, by cancer, by sample and by end user.

By Type –

The liquid biopsy for cancer diagnostics market is segmented by type into:

a) Product

b) Services

The product market was the largest segment of the liquid biopsy for cancer diagnostics market segmented by type, accounting for 72.93% or $6,728.96 million of the total in 2024. Going forward, the services segment is expected to be the fastest growing segment in the liquid biopsy for cancer diagnostics market segmented by type, at a CAGR of 17.90% during 2024-2029.

By Cancer –

The liquid biopsy for cancer diagnostics market is segmented by cancer into:

a) Lung Cancer

b) Breast Cancer

c) Colon Cancer

d) Other Cancers

The lung cancer market was the largest segment of the liquid biopsy for cancer diagnostics market segmented by cancer, accounting for 32.67% or $3,014.45 million of the total in 2024. Going forward, the lung cancer segment is expected to be the fastest growing segment in the liquid biopsy for cancer diagnostics market segmented by cancer, at a CAGR of 18.99% during 2024-2029.

By Sample –

The liquid biopsy for cancer diagnostics market is segmented by sample into:

a) Blood

b) Urine

c) Saliva

The blood market was the largest segment of the liquid biopsy for cancer diagnostics market segmented by sample, accounting for 79.82% or $7,365.24 million of the total in 2024. Going forward, the urine segment is expected to be the fastest growing segment in the liquid biopsy for cancer diagnostics market segmented by sample, at a CAGR of 18.84% during 2024-2029.

By End User –

The liquid biopsy for cancer diagnostics market is segmented by end user into:

a) Hospitals

b) Diagnostic Centers

c) Other End Users

The hospitals market was the largest segment of the liquid biopsy for cancer diagnostics market segmented by end user, accounting for 55.83% or $5,151.13 million of the total in 2024. Going forward, the diagnostic centers segment is expected to be the fastest growing segment in the liquid biopsy for cancer diagnostics market segmented by end user, at a CAGR of 19.95% during 2024-2029.

By Geography - The liquid biopsy for cancer diagnostics market is segmented by geography into:

o Asia Pacific

• China

• India

• Japan

• Australia

• Indonesia

• South Korea

o North America

• USA

• Canada

o South America

• Brazil

o Western Europe

• France

• Germany

• UK

• Italy

• Spain

o Eastern Europe

• Russia

o Middle East

o Africa

North America was the largest region in the liquid biopsy for cancer diagnostics market, accounting for 47.21% or $4,355.95 million of the total in 2024. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the liquid biopsy for cancer diagnostics market will be Asia Pacific and Western Europe where growth will be at CAGRs of 18.06% and 17.14% respectively. These will be followed by North America and South America where the markets are expected to grow at CAGRs of 16.37% and 14.04% respectively.

Liquid Biopsy For Cancer Diagnostics Market Competitive Landscape

Major Competitors are:

F. Hoffmann-La Roche AG

Thermo Fisher Scientific Inc.

Guardant Health Inc.

Illumina Inc.

Exact Sciences Corporation

Other Competitors Include:

Natera Inc.

Johnson & Johnson Services Inc.

Bio-Rad Laboratories Inc.

Caris Life Science

Sysmex Corporation

Strand Life Sciences

Adicon Holdings Limited

SOPHiA GENETICS SA

QIAGEN N. V.

Novigenix

Roche Diagnostics Polska Sp. z o.o.

Janssen Diagnostics LLC

Twist Bioscience

Biocept

BioMark Diagnostics Inc.

GRAIL, Inc.

Foundation Medicine, Inc.

GeneCentric Therapeutics Inc.

DGLAB

Oncoclínicas Group

Grupo Fleury

Detectiome

Anwa Medical Company

Syndicate Bio

PathCare

Axaitech

Book your 30 minutes free consultation with our research experts

Contact Us

Liquid Biopsy For Cancer Diagnostics Market Size

The global liquid biopsy for cancer diagnostics market reached a value of nearly $9,227.13 million in 2024, having grown at a compound annual growth rate (CAGR) of 15.72% since 2019. The market is expected to grow from $9,227.13 million in 2024 to $19,818.89 million in 2029 at a rate of 16.52%. The market is then expected to grow at a CAGR of 16.20% from 2029 and reach $41,977.81 million in 2034.  

Growth in the historic period resulted from the rising demand for personalized medicine, rise in healthcare expenditure, increasing number of clinical trials and government initiatives for research and development in healthcare. Factors that negatively affected growth in the historic period was limited reimbursement policies.

Going forward, the increasing cancer prevalence, growing aging population and growing cancer research investments will drive the growth. Factor that could hinder the growth of the liquid biopsy for cancer diagnostics market in the future include lack of trained personnel and high cost of technology.  

Liquid Biopsy For Cancer Diagnostics Market Drivers

The key drivers of the liquid biopsy for cancer diagnostics market include:

Increasing Cancer Prevalence

Increasing cancer prevalence is expected to be a key driver of the growth of the liquid biopsy for cancer diagnostics market in the forecast period. Liquid biopsies provide a non-invasive approach to the early detection of cancer, which is increasingly important as cancer cases continue to rise. By enabling early diagnosis, liquid biopsies facilitate prompt treatment, potentially enhancing patient outcomes and improving overall healthcare efficiency. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, increasing cancer prevalence will drive demand for liquid biopsy for cancer diagnostics going forward.

Liquid Biopsy For Cancer Diagnostics Market Restraints

The key restraints on the liquid biopsy for cancer diagnostics market include:

Lack of Trained Personnel

The lack of trained personnel is expected to limit the growth of the liquid biopsy for the cancer diagnostics market in the forecast period. If the healthcare workforce is not adequately trained, the likelihood of incorrect interpretations of liquid biopsy results rises. This can result in misdiagnoses, unnecessary treatments, or missed opportunities for early cancer detection, potentially damaging patient confidence in the technology and hindering its widespread adoption. For instance, in September 2024, according to Oncology Nursing News, a US-based provider of news and clinical insights for oncology nursing professionals, by 2025, the United States is expected to face a shortage of between 200,000 and 450,000 oncology nurses. Therefore, a lack of trained personnel may hinder the growth of liquid biopsy in the cancer diagnostics market.

Liquid Biopsy For Cancer Diagnostics Market Trends

Major trends shaping the liquid biopsy for cancer diagnostics market include:

High-Precision Liquid Biopsy For Identifying Cancer Biomarkers

Major companies operating in the liquid biopsy for cancer diagnostics market are focusing on developing high-precision liquid biopsy for identifying cancer biomarkers. High-precision liquid biopsy refers to advanced techniques used to analyze circulating biomarkers in bodily fluids, primarily blood, to detect and monitor cancer with a high degree of accuracy. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics software and services provider, launched the somatic advantage 74 Liquid Biopsy (SA74 LB) test. This high-precision liquid biopsy test detects circulating tumor deoxyribonucleic acid (ctDNA) in blood samples from cancer patients, analyzing 74 clinically significant genes to offer valuable insights for treatment decisions. The SA74 LB test is designed to be minimally invasive, requiring only a blood sample, thus providing a more convenient alternative to traditional tissue biopsies. Utilizing Unique Molecular Identifiers (UMIs) ensures high-accuracy detection of genetic variants, enabling clinicians to identify potential biomarkers and optimize treatment strategies effectively.  

Advancements In Automated Liquid Biopsy Technologies For Oncology And Prenatal Cares

Companies operating in the liquid biopsy for cancer diagnostics market are revolutionizing next-generation automated liquid biopsy technologies for oncology and prenatal care.  This automation reduces manual handling and increases reproducibility, which is important for clinical diagnostics where precision is critical. For instance, in October 2024, QIAGEN, Germany-based and specializing in sample and assay technologies, announced the expansion of its automated liquid biopsy portfolio, aimed at advancing applications in oncology, prenatal care, and organ transplantation. The enhancements include an upgraded EZ1&2 ccfDNA (circulating cell-free deoxyribonucleic acid) Kit, capable of processing up to 24 samples using 10 mL (milliliter) of serum or plasma, along with the introduction of a new urine protocol. Additionally, the company launched the QIAsymphony DSP Circulating DNA Kits, designed for the fully automated extraction of circulating cell-free DNA (ccfDNA) from larger sample volumes. These innovations are tailored to improve the sensitivity and accuracy of liquid biopsies, particularly for the detection of low-frequency mutations in cancer diagnostics while ensuring compliance with regulatory standards for in vitro diagnostics.

Opportunities And Recommendations In The Liquid Biopsy For Cancer Diagnostics Market

Opportunities – The top opportunities in the liquid biopsy for cancer diagnostics market segmented by type will arise in the product segment, which will gain $7,398.53 million of global annual sales by 2029. The top opportunities in the liquid biopsy for cancer diagnostics market segmented by cancer will arise in the lung cancer segment, which will gain $4,175.64 million of global annual sales by 2029. The top opportunities in the liquid biopsy for cancer diagnostics market segmented by end user will arise in the hospitals segment, which will gain $5,169.11 million of global annual sales by 2029. The top opportunities in the liquid biopsy for cancer diagnostics market segmented by sample will arise in the blood segment, which will gain $8,227.62 million of global annual sales by 2029. The liquid biopsy for cancer diagnostics market size will gain the most in the USA at $4,287.28 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the liquid biopsy for cancer diagnostics companies to  focus on developing high-precision liquid biopsy solutions, focus on advancing automated liquid biopsy technologies, focus on advancing next-generation tools for enhanced cancer screening, focus on advancing next-generation liquid biopsy solutions, focus on enhancing tumor detection and profiling in liquid biopsy, expand in emerging markets, focus on expanding distribution channels for liquid biopsy solutions, focus on developing competitive and accessible pricing strategies, focus on building awareness through targeted educational campaigns, focus on strengthening digital and social media marketing and focus on targeting hospitals and diagnostic centers for enhanced market penetration.

    Table Of Contents

    1 Executive Summary

    1.1 Liquid Biopsy For Cancer Diagnostics – Market Attractiveness And Macro Economic Landscape

    2 Table Of Contents

    3 List Of Tables

    4 List Of Figures

    5 Report Structure

    6 Market Characteristics

    6.1 General Market Definition

    6.2 Summary

    6.3 Liquid Biopsy For Cancer Diagnostics Market Definition And Segmentations

    6.4 Market Segmentation By Type

    6.4.1 Product

    6.4.2 Services

    6.5 Market Segmentation By Cancer

    6.5.1 Lung Cancer

    6.5.2 Breast Cancer

    6.5.3 Colon Cancer

    6.5.4 Other Cancers

    6.6 Market Segmentation By Sample

    6.6.1 Blood

    6.6.2 Urine

    6.6.3 Saliva

    6.7 Market Segmentation By End User

    6.7.1 Hospitals

    6.7.2 Diagnostic Centers

    6.7.3 Other End Users

    7 Major Market Trends

    7.1 High-Precision Liquid Biopsy For Identifying Cancer Biomarkers

    7.2 Advancements In Automated Liquid Biopsy Technologies For Oncology And Prenatal Care

    7.3 Next-Generation Liquid Biopsy Tool Improves Cancer Screening Capabilities

    7.4 Technological Advancement In Liquid Biopsy For Personalized Cancer Treatment

    7.5 Enhancing Tumor Detection And Profiling With Liquid Biopsy

    8 Liquid Biopsy For Cancer Diagnostics Market – Macro-Economic Scenario

    8.1 COVID-19 Impact On The Liquid Biopsy For Cancer Diagnostics Market

    8.2 Impact Of The War In Ukraine On The Liquid Biopsy For Cancer Diagnostics Market

    8.3 Impact Of High Inflation On The Liquid Biopsy For Cancer Diagnostics Market

    9 Global Market Size and Growth

    9.1 Market Size

    9.2 Historic Market Growth, 2019 – 2024, Value ($ Million)

    9.2.1 Market Drivers 2019 – 2024

    9.2.2 Market Restraints 2019– 2024

    9.3 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

    9.3.1 Market Drivers 2024 – 2029

    9.3.2 Market Restraints 2024 – 2029

    10 Global Liquid Biopsy For Cancer Diagnostics Market Segmentation

    10.1 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    10.2 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    10.3 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    10.4 Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    11 Liquid Biopsy For Cancer Diagnostics Market, Regional and Country Analysis

    11.1 Global Liquid Biopsy For Cancer Diagnostics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    11.2 Global Liquid Biopsy For Cancer Diagnostics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12 Asia-Pacific Market

    12.1 Summary

    12.2 Market Overview

    12.2.1 Region Information

    12.2.2 Market Information

    12.2.3 Background Information

    12.2.4 Government Initiatives

    12.2.5 Regulations

    12.2.6 Regulatory Bodies

    12.2.7 Major Associations

    12.2.8 Taxes Levied

    12.2.9 Corporate Tax Structure

    12.2.10 Investments

    12.2.11 Major Companies

    12.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.4 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.5 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.6 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market: Country Analysis

    12.7 China Market

    12.8 Summary

    12.9 Market Overview

    12.9.1 Country Information

    12.9.2 Market Information

    12.9.3 Background Information

    12.9.4 Government Initiatives

    12.9.5 Regulations

    12.9.6 Regulatory Bodies

    12.9.7 Major Associations

    12.9.8 Taxes Levied

    12.9.9 Corporate Tax Structure

    12.9.10 Investments

    12.9.11 Major Companies

    12.10 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.11 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.12 China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.13 India Market

    12.14 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.15 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.16 India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.17 Japan Market

    12.18 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.19 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.20 Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.21 Australia Market

    12.22 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.23 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.24 Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.25 Indonesia Market

    12.26 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.27 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.28 Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.29 South Korea Market

    12.30 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.31 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    12.32 South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13 Western Europe Market

    13.1 Summary

    13.2 Market Overview

    13.2.1 Region Information

    13.2.2 Market Information

    13.2.3 Background Information

    13.2.4 Government Initiatives

    13.2.5 Regulations

    13.2.6 Regulatory Bodies

    13.2.7 Major Associations

    13.2.8 Taxes Levied

    13.2.9 Corporate tax structure

    13.2.10 Investments

    13.2.11 Major Companies

    13.3 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.4 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.5 Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.6 Western Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis

    13.7 UK Market

    13.8 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.9 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.10 UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.11 Germany Market

    13.12 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.13 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.14 Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.15 France Market

    13.16 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.17 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.18 France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.19 Italy Market

    13.20 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.21 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.22 Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.23 Spain Market

    13.24 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.25 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    13.26 Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14 Eastern Europe Market

    14.1 Summary

    14.2 Market Overview

    14.2.1 Region Information

    14.2.2 Market Information

    14.2.3 Background Information

    14.2.4 Government Initiatives

    14.2.5 Regulations

    14.2.6 Regulatory Bodies

    14.2.7 Major Associations

    14.2.8 Taxes Levied

    14.2.9 Corporate Tax Structure

    14.2.10 Major companies

    14.3 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14.4 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14.5 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14.6 Eastern Europe Liquid Biopsy For Cancer Diagnostics Market: Country Analysis

    14.7 Russia Market

    14.8 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14.9 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    14.10 Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15 North America Market

    15.1 Summary

    15.2 Market Overview

    15.2.1 Region Information

    15.2.2 Market Information

    15.2.3 Background Information

    15.2.4 Government Initiatives

    15.2.5 Regulations

    15.2.6 Regulatory Bodies

    15.2.7 Major Associations

    15.2.8 Taxes Levied

    15.2.9 Corporate Tax Structure

    15.2.10 Investments

    15.2.11 Major Companies

    15.3 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.4 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.5 North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.6 North America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis

    15.7 USA Market

    15.8 Summary

    15.9 Market Overview

    15.9.1 Country Information

    15.9.2 Market Information

    15.9.3 Background Information

    15.9.4 Government Initiatives

    15.9.5 Regulations

    15.9.6 Regulatory Bodies

    15.9.7 Major Associations

    15.9.8 Taxes Levied

    15.9.9 Corporate Tax Structure

    15.9.10 Investments

    15.9.11 Major Companies

    15.10 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.11 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.12 USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.13 Canada Market

    15.14 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.15 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    15.16 Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16 South America Market

    16.1 Summary

    16.2 Market Overview

    16.2.1 Region Information

    16.2.2 Market Information

    16.2.3 Background Information

    16.2.4 Government Initiatives

    16.2.5 Regulations

    16.2.6 Regulatory Bodies

    16.2.7 Major Associations

    16.2.8 Taxes Levied

    16.2.9 Corporate Tax Structure

    16.2.10 Major Companies

    16.3 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16.4 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16.5 South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16.6 South America Liquid Biopsy For Cancer Diagnostics Market: Country Analysis

    16.7 Brazil Market

    16.8 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16.9 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    16.10 Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    17 Middle East Market

    17.1 Summary

    17.2 Market Overview

    17.2.1 Region Information

    17.2.2 Market Information

    17.2.3 Background Information

    17.2.4 Government Initiatives

    17.2.5 Regulations

    17.2.6 Regulatory Bodies

    17.2.7 Major Associations

    17.2.8 Taxes Levied

    17.2.9 Corporate Tax Structure

    17.2.10 Major Companies

    17.3 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    17.4 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    17.5 Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    18 Africa Market

    18.1 Summary

    18.2 Market Overview

    18.2.1 Region Information

    18.2.2 Market Information

    18.2.3 Background Information

    18.2.4 Government Initiatives

    18.2.5 Regulations

    18.2.6 Regulatory Bodies

    18.2.7 Major Associations

    18.2.8 Taxes Levied

    18.2.9 Corporate Tax Structure

    18.2.10 Major Companies

    18.3 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    18.4 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    18.5 Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

    19 Competitive Landscape And Company Profiles

    19.1 Company Profiles

    19.2 F. Hoffman-La Roche Ltd

    19.2.1 Company Overview

    19.2.2 Products And Services

    19.2.3 Business Strategy

    19.2.4 Financial Overview

    19.3 Thermo Fisher Scientific Inc

    19.3.1 Company Overview

    19.3.2 Products And Services

    19.3.3 Business Strategy

    19.3.4 Financial Overview

    19.4 Guardant Health Inc

    19.4.1 Company Overview

    19.4.2 Products And Services

    19.4.3 Business Strategy

    19.4.4 Financial Overview

    19.5 Illumina Inc.

    19.5.1 Company Overview

    19.5.2 Products And Services

    19.5.3 Financial Overview

    19.6 Exact Sciences Corporation

    19.6.1 Company Overview

    19.6.2 Products And Services

    19.6.3 Business Strategy

    19.6.4 Financial Overview

    20 Other Major And Innovative Companies

    20.1 Natera Inc.

    20.1.1 Company Overview

    20.1.2 Products And Services

    20.2 Johnson & Johnson Services Inc.

    20.2.1 Company Overview

    20.2.2 Products And Services

    20.3 Bio-Rad Laboratories Inc.

    20.3.1 Company Overview

    20.3.2 Products And Services

    20.4 Caris Life Science

    20.4.1 Company Overview

    20.4.2 Products And Services

    20.5 Sysmex Corporation

    20.5.1 Company Overview

    20.5.2 Products And Services

    20.6 Qiagen NV

    20.6.1 Company Overview

    20.6.2 Products And Services

    20.7 Myriad Genetic Laboratories Inc.

    20.7.1 Company Overview

    20.7.2 Products And Services

    20.8 Invitae Corporation

    20.8.1 Company Overview

    20.8.2 Products And Services

    20.9 Freenome Holdings Inc.

    20.9.1 Company Overview

    20.9.2 Products And Services

    20.1 Tempus Labs, Inc.

    20.10.1 Company Overview

    20.10.2 Products And Services

    20.11 MDxHealth SA

    20.11.1 Company Overview

    20.11.2 Products And Services

    20.12 NeoGenomics Laboratories Inc.

    20.12.1 Company Overview

    20.12.2 Products And Services

    20.13 ExosomeDx

    20.13.1 Company Overview

    20.13.2 Products And Services

    20.14 Biodesix Inc.

    20.14.1 Company Overview

    20.14.2 Products And Services

    20.15 Biocartis Group NV.

    20.15.1 Company Overview

    20.15.2 Products And Services

    21 Competitive Benchmarking

    22 Competitive Dashboard

    23 Key Mergers And Acquisitions

    23.1 Quest Diagnostics Acquired Haystack Oncology

    23.2 Exact Sciences Corporation Acquired Resolution Bioscience, Inc.

    23.3 Exact Sciences Corporation Acquired Thrive Earlier Detection

    24 Opportunities And Strategies

    24.1 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Countries Offering Most New Opportunities

    24.2 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Segments Offering Most New Opportunities

    24.3 Global Liquid Biopsy For Cancer Diagnostics Market In 2029 – Growth Strategies

    24.3.1 Market Trend Based Strategies

    24.3.2 Competitor Strategies

    25 Liquid Biopsy For Cancer Diagnostics Market, Conclusions And Recommendations

    25.1 Conclusions

    25.2 Recommendations

    25.2.1 Product

    25.2.2 Place

    25.2.3 Price

    25.2.4 Promotion

    25.2.5 People

    26 Appendix

    26.1 Geographies Covered

    26.2 Market Data Sources

    26.3 Research Methodology

    26.4 Currencies

    26.5 The Business Research Company

    26.6 Copyright and Disclaimer

List Of Tables

    Table 1: Global Liquid Biopsy For Cancer Diagnostics Market, Historic, 2019 – 2024, $ Million
  • Table 2: Global Liquid Biopsy For Cancer Diagnostics Market, Forecast, 2024 – 2029, 2034F , $ Million
  • Table 3: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 4: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 5: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 6: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 7: Global Liquid Biopsy For Cancer Diagnostics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 8: Global Liquid Biopsy For Cancer Diagnostics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 9: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
  • Table 10:  Asia-Pacific Population, By Country, 2019-2029, Millions
  • Table 11: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 12: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 13: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 14: China GDP Per Capita, 2019-2024, $
  • Table 15:  China Population, 2019-2029, Millions
  • Table 16: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 17: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 18: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 19: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 20: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 21: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 22: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 23: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 24: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 25: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 26: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 27: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 28: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 29: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 30: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 31: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 32: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 33: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 34: Western Europe GDP Per Capita, By Country, 2019-2024, $
  • Table 35:  Western Europe Population, By Country, 2019-2029, Millions
  • Table 36: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 37: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 38: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 39: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 40: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 41: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 42: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 43: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 44: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 45: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 46: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 47: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 48: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 49: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 50: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 51: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 52: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 53: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 54: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
  • Table 55:  Eastern Europe Population, By Country, 2019-2029, Millions
  • Table 56: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 57: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 58: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 59: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 60: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 61: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 62: North America GDP Per Capita, By Country, 2019-2024, $
  • Table 63:  North America Population, By Country, 2019-2029, Millions
  • Table 64: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 65: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 66: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 67: USA GDP Per Capita, 2019-2024, $
  • Table 68:  USA Population, 2019-2029, Millions
  • Table 69: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 70: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 71: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 72: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 73: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 74: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 75: South America GDP Per Capita, By Country, 2019-2024, $
  • Table 76:  South America Population, By Country, 2019-2029, Millions
  • Table 77: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 78: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 79: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 80: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 81: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 82: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 83: Middle East GDP Per Capita, By Country, 2019-2024, $
  • Table 84:  Middle East Population, By Country, 2019-2029, Millions
  • Table 85: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 86: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 87: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 88: Africa GDP Per Capita, By Country, 2019-2024, $
  • Table 89:  Africa Population, By Country, 2019-2029, Millions
  • Table 90: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 91: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 92: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Table 93: Global Liquid Biopsy For Cancer Diagnostics Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
  • Table 94: F. Hoffmann-La Roche Ltd – Financial Overview, 2019 – 2023, $Billion
  • Table 95: Thermo Fisher Scientific Inc – Financial Overview, 2019 – 2023, $ Billion
  • Table 96: Guardant Health Inc – Financial Overview, 2019 – 2023, $ Billion
  • Table 97: Illumina Inc – Financial Overview, 2019 – 2023, $ Billion
  • Table 98: Exact Sciences Corporation – Financial Overview, 2019 – 2023, $ Billion
  • Table 99: Liquid Biopsy For Cancer Diagnostics Market, Competitive Benchmarking (In USD Millions)
  • Table 100: Liquid Biopsy For Cancer Diagnostics Market, Competitive Dashboard
  • Table 101: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Million), 2024 – 2029, By Country
  • Table 102: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Million), Segmentation By Type, 2024 – 2029
  • Table 103: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Million), Segmentation By Cancer, 2024 – 2029
  • Table 104: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Million), Segmentation By End User, 2024 – 2029
  • Table 105: Global Liquid Biopsy For Cancer Diagnostics Market Size Gain ($ Million), Segmentation By Sample, 2024 – 2029
  • Table 106: Liquid Biopsy For Cancer Diagnostics Market Data Sources

List Of Figures

    Figure 1: Global Liquid Biopsy For Cancer Diagnostics Market Segmentation By Type
  • Figure 2: Global Liquid Biopsy For Cancer Diagnostics Market Segmentation By Cancer
  • Figure 3: Global Liquid Biopsy For Cancer Diagnostics Market Segmentation By Sample
  • Figure 4: Global Liquid Biopsy For Cancer Diagnostics Market Segmentation By End User
  • Figure 5: Global Liquid Biopsy For Cancer Diagnostics Market, Historic, 2019 – 2024, $ Million
  • Figure 6: Global Liquid Biopsy For Cancer Diagnostics Market, Forecast, 2024 – 2029, 2034F , $ Million
  • Figure 7: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 8: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 9: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 10: Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Sample, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 11: Global Liquid Biopsy For Cancer Diagnostics Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 12: Global Liquid Biopsy For Cancer Diagnostics Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 13: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 14: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 15: Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 16: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 17: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 18: China Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 19: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 20: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 21: India Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 22: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 23: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 24: Japan Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 25: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 26: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 27: Australia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 28: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 29: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 30: Indonesia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 31: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 32: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 33: South Korea Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 34: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 35: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 36: Western Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 37: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 38: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 39: UK Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 40: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 41: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 42: Germany Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 43: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 44: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 45: France Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 46: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 47: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 48: Italy Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 49: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 50: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 51: Spain Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 52: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 53: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 54: Eastern Europe Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 55: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 56: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 57: Russia Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 58: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 59: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 60: North America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 61: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 62: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 63: USA Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 64: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 65: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 66: Canada Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 67: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 68: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 69: South America Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 70: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 71: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 72: Brazil Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 73: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 74: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 75: Middle East Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 76: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 77: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By Cancer, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 78: Africa Liquid Biopsy For Cancer Diagnostics Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
  • Figure 79: Global Liquid Biopsy For Cancer Diagnostics, Key Competitor Estimated Market Shares, 2023, Percentage (%)
  • Figure 80: F. Hoffmann-La Roche Ltd – Financial Overview, 2019 – 2023, $ Billion
  • Figure 81: Thermo Fisher Scientific Inc – Financial Overview, 2019 – 2023, $ Billion
  • Figure 82: Guardant Health Inc – Financial Overview, 2019 – 2023, $ Billion
  • Figure 83: Illumina Inc – Financial Overview, 2019 – 2023, $ Billion
  • Figure 84: Honeywell International – Financial Overview, 2019 – 2023, $ Billion
  • Figure 85: Geographic Regions Covered

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

Global Healthcare Automation Market 2022 – Market Opportunities And Strategies

Read More

Global Central Lab Market 2022 – Market Opportunities And Strategies

Read More

What Is The Biohacking Market Overview In 2022?

Read More

How Will The Healthcare Claims Management Solutions Market Grow In 2022?

Read More

Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Dimension Stone Mining Global Market Report 2020 - By Type (Marble, Granite, Limestone, Sandstone)

View Report

Truck Transportation Global Market Report 2020 - By Type (General Freight Trucking, Specialized Freight Trucking Local General Freight Trucking, Long-Distance General Freight Trucking, Automobiles And Heavy Equipment, Bulk Liquids, Dry Bulk Materials, Forest Products, Refrigerated Goods)

View Report

Stone Mining And Quarrying Global Market Report 2020 - By Type (Dimension Stone Mining, Crushed Stone Mining), By Organization Size (large Enterprises, Small And Medium Enterprises), COVID-19 Impact

View Report

Crushed Stone Mining Global Market Report 2020 - By Type (Limestone Mining, Granite Mining)

View Report

Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Medical Billing Outsourcing Global Market Report 2025 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2025-2034

View Report